PBMs Are Breaking Down Barriers to Expand Access to Biosimilars and Lower Consumer Costs

PBMs Are Breaking Down Barriers to Expand Access to Biosimilars and Lower Consumer Costs

While Drug Companies Drive Up Drug Prices with Anti-Competitive Behavior, PBMs Continue to Innovate and Lower Costs for Consumers As policymakers tackle America’s prescription drug affordability challenge, it’s important to remember that Big Pharma sets the price of the prescription drugs – and the price is the number one problem when it comes to Americans facing difficulty affording their prescription drugs. Drug companies raise drug prices yea…